StonvexLoading…
StonvexStonvexStonvexCore line items from ATRO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q2 2026 2026-04-04 | Annual 2025 2025-12-31 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|---|
Revenue | $250.74M | $230.62M | $862.13M | $622.06M | $410.61M |
Operating Income | Not available | $27.23M | $76.41M | $40.95M | $17.89M |
Net Income | Not available | $25.54M | $29.36M | $-256.00K | $10.84M |
EPS (Diluted) | $0.69 | $0.67 | $0.81 | $-0.01 | $0.30 |
Total Assets | Not available | $747.14M | $706.68M | $682.19M | $646.69M |
Total Liabilities | Not available | $585.44M | $566.60M | $573.28M | $375.12M |
Cash & Equivalents | Not available | $11.87M | $18.18M | $13.48M | $13.46M |
Free Cash Flow OCF − CapEx | Not available | $-554.00K | $43.12M | $27.31M | $6.30M |
Shares Outstanding | Not available | 38.22M | 36.46M | 35.37M | 36.06M |